Kymera Therapeutics soars as Sanofi expands phase 2 trials
Go back to Kymera Therapeutics soars as Sanofi expands phase 2 trials| (NASDAQ: KYMR) | Delayed: 121.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $121.50 | 52 Week High | $ | |||
| Open | $121.50 | 52 Week Low | $ | |||
| Day High | $121.50 | P/E | N/A | |||
| Day Low | $121.50 | EPS | $ | |||
| Volume | 2,747 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.15 | 52 Week High | $44.76 | |||
| Open | $45.15 | 52 Week Low | $36.81 | |||
| Day High | $45.15 | P/E | N/A | |||
| Day Low | $45.15 | EPS | $0.00 | |||
| Volume | 10,458 | |||||
